<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Human Anti-Mesothelin Monoclonal Antibodies for the Treatment of Human Cancers</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive License: The Development of Human Anti-Mesothelin Monoclonal Antibodies for the Treatment of Human Cancers</h1>
    <p class="timestamp">Published: 2012-02-01 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive evaluation option license to practice the inventions embodied in U.S. Patent Application 61/040,005 entitled "Human Monoclonal Antibodies Specific for Mesothelin" [HHS Ref. E-079-2008/0- US-01], PCT Application PCT/US2009/038228 entitled "Human Monoclonal Antibody Against Mesothelin" [HHS...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2012-2213</p>
    <p><strong>Publication Date:</strong> 2012-02-01</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/02/01/2012-2213/prospective-grant-of-exclusive-license-the-development-of-human-anti-mesothelin-monoclonal">https://www.federalregister.gov/documents/2012/02/01/2012-2213/prospective-grant-of-exclusive-license-the-development-of-human-anti-mesothelin-monoclonal</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-2213</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
